购物车
- 全部删除
- 您的购物车当前为空
FK-330(FR-260330) 是一种新型口服活性诱导型一氧化氮合酶抑制剂,具有潜在的抗癌和抗肿瘤活性,可预防大鼠肝移植缺血和再灌注损伤。
FK-330(FR-260330) 是一种新型口服活性诱导型一氧化氮合酶抑制剂,具有潜在的抗癌和抗肿瘤活性,可预防大鼠肝移植缺血和再灌注损伤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,300 | 现货 | |
5 mg | ¥ 3,250 | 现货 | |
10 mg | ¥ 4,750 | 现货 | |
25 mg | ¥ 7,480 | 现货 | |
50 mg | ¥ 9,870 | 现货 | |
100 mg | ¥ 13,600 | 现货 | |
500 mg | ¥ 27,300 | 现货 |
产品描述 | FK-330 (FR-260330) is a novel orally active inducible nitric oxide synthase inhibitor with potential anticancer and antitumor activity that prevents ischemia and reperfusion injury in rat liver transplantation. |
别名 | LS-192510, FR-260330, FK330, FK 330 |
分子量 | 617.02 |
分子式 | C29H28ClF3N6O4 |
CAS No. | 442198-67-6 |
Smiles | [C@H](CC1=CC=CC=N1)(C(NCC(=O)N2CCC(OC=3C=C(C(F)(F)F)N=CN3)CC2)=O)NC(/C=C/C4=CC=C(Cl)C=C4)=O |
密度 | 1.378 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (81.03 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容